Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Assets (2021 - 2025)

Biote has reported Assets over the past 5 years, most recently at $107.6 million for Q4 2025.

  • Quarterly results put Assets at $107.6 million for Q4 2025, down 12.06% from a year ago — trailing twelve months through Dec 2025 was $107.6 million (down 12.06% YoY), and the annual figure for FY2025 was $107.6 million, down 12.06%.
  • Assets for Q4 2025 was $107.6 million at Biote, down from $111.3 million in the prior quarter.
  • Over the last five years, Assets for BTMD hit a ceiling of $319.0 million in Q1 2021 and a floor of $54.3 million in Q4 2021.
  • Median Assets over the past 5 years was $120.8 million (2023), compared with a mean of $157.6 million.
  • Peak annual rise in Assets hit 105.49% in 2022, while the deepest fall reached 65.57% in 2022.
  • Biote's Assets stood at $54.3 million in 2021, then soared by 105.49% to $111.6 million in 2022, then skyrocketed by 39.1% to $155.3 million in 2023, then fell by 21.2% to $122.4 million in 2024, then dropped by 12.06% to $107.6 million in 2025.
  • The last three reported values for Assets were $107.6 million (Q4 2025), $111.3 million (Q3 2025), and $104.8 million (Q2 2025) per Business Quant data.